The developer of Russia’s COVID-19 vaccine Sputnik V has pledged to make it available for less than $10 per dose – or $20 per two-dose course – on the same day as revealing new clinical data ...
The Russian Ministry of Health registered the nasal version of the COVID-19 vaccine Sputnik V, developed by the Gamaleya Institute of that country. The injectable immunizer was the first to be ...
Slovakia’s febrile politics and incompetent handling of the pandemic has made it vulnerable to Russian mischief using its Sputnik vaccine. In January, Prime Minister Igor Matovič was still ...
Seamless reading experience. Save your favourite. Anvisa's five-strong board voted unanimously not to approve the Russian vaccine after technical staff had highlighted "inherent risks" and ...
According to media reports, Pharmasyntez also contributed to the production of Russia's Sputnik vaccine during the COVID-19 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results